CN Stock MarketDetailed Quotes

PharmaResources (301230)

Watchlist
  • 40.06
  • -0.97-2.36%
Market Closed Apr 17 15:00 CST
5.59BMarket Cap152.90P/E (TTM)

PharmaResources (301230) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
31.43%514.4M
32.73%352.74M
29.61%169.43M
11.18%544.47M
6.59%391.4M
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
Operating revenue
31.43%514.4M
32.73%352.74M
29.61%169.43M
11.18%544.47M
6.59%391.4M
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
Other operating revenue
----
134.18%14.91M
----
57.21%14.52M
----
-25.44%6.37M
----
36.64%9.24M
----
427.56%8.54M
Total operating cost
22.06%484.12M
24.50%329.75M
16.73%157.97M
23.03%553.73M
24.18%396.61M
32.21%264.86M
29.49%135.33M
9.94%450.09M
9.86%319.39M
9.98%200.33M
Operating cost
24.03%370.12M
25.50%254.22M
16.91%121.33M
22.46%414.54M
24.28%298.42M
35.64%202.57M
33.19%103.78M
11.98%338.51M
13.20%240.12M
16.60%149.34M
Operating tax surcharges
35.49%1.7M
60.37%1.28M
41.46%738.07K
42.08%1.76M
37.04%1.25M
43.74%797.96K
66.97%521.75K
-25.27%1.24M
-26.84%915.16K
-28.30%555.13K
Operating expense
1.21%9.76M
4.14%7.13M
13.82%3.62M
7.77%13.9M
8.51%9.64M
23.93%6.84M
24.22%3.18M
58.85%12.9M
76.95%8.89M
104.56%5.52M
Administration expense
43.12%70.24M
47.26%46.7M
43.65%23.15M
24.05%75.28M
11.82%49.08M
10.05%31.72M
21.04%16.11M
-15.77%60.69M
-22.93%43.89M
-29.25%28.82M
Financial expense
51.32%3.51M
1,172.93%1.42M
-11.76%401.03K
268.20%983.29K
173.79%2.32M
103.51%111.85K
92.84%454.45K
92.08%-584.6K
55.44%-3.14M
22.33%-3.19M
-Interest expense (Financial expense)
-10.47%6.31M
-10.12%4.27M
-9.87%2.17M
69.93%9.28M
139.64%7.05M
134.01%4.75M
130.56%2.41M
13.97%5.46M
-19.27%2.94M
-17.18%2.03M
-Interest Income (Financial expense)
49.72%-1.33M
43.12%-1.04M
36.52%-459.73K
43.35%-3.13M
36.69%-2.64M
48.18%-1.82M
76.32%-724.22K
-91.64%-5.53M
-857.76%-4.16M
-1,698.18%-3.52M
Research and development
-19.80%28.79M
-16.75%19M
-22.60%8.73M
26.58%47.26M
25.01%35.9M
18.33%22.82M
10.93%11.27M
14.34%37.34M
27.95%28.72M
38.04%19.28M
Credit Impairment Loss
-111.99%-2.79M
-139.57%-3.36M
-124.01%-1.78M
-373.60%-1.29M
-768.96%-1.32M
-239.30%-1.4M
-1,289.62%-795.77K
-208.10%-273.14K
-146.85%-151.34K
496.16%1.01M
Asset Impairment Loss
-233.57%-3.05M
-166.95%-1.8M
-130.93%-1.01M
105.37%649.77K
194.84%2.28M
233.95%2.69M
338.62%3.26M
-458.93%-12.09M
-50.42%-2.41M
3.98%-2.01M
Other net revenue
-85.08%1.74M
-102.57%-246.69K
-105.41%-344.43K
691.28%12.89M
597.10%11.64M
1,826.45%9.59M
1,226.30%6.36M
-164.76%-2.18M
167.16%1.67M
-25.57%-555.47K
Fair value change income
29.86%5.19M
1,700.31%3.31M
48.23%1.77M
-10.91%4.97M
69.68%4M
106.16%184.02K
32.56%1.19M
5,716.89%5.58M
1,568.97%2.36M
-1,110.18%-2.99M
Invest income
-96.99%105.38K
-98.02%105.38K
-96.95%59.18K
446.65%3.44M
382.56%3.5M
76.69%5.33M
320.44%1.94M
4.17%628.46K
21.08%726.01K
539.55%3.02M
Asset deal income
----
----
----
----
----
----
----
--5.8K
--5.8K
--3.02K
Other revenue
-28.28%2.27M
-46.39%1.49M
-19.87%615.66K
29.07%5.13M
178.36%3.17M
569.38%2.79M
85.95%768.29K
-16.79%3.97M
-22.12%1.14M
-66.88%416.43K
Operating profit
397.68%32.02M
116.66%22.74M
530.10%11.12M
-90.30%3.63M
-87.00%6.43M
-71.45%10.5M
-89.84%1.76M
-48.60%37.44M
17.79%49.49M
58.00%36.77M
Add:Non operating Income
-86.18%21.69K
-89.20%13.35K
-100.00%1.44
619.65%189.12K
2,225.16%156.95K
1,731.40%123.62K
1,877.39%121.61K
-87.22%26.28K
-96.72%6.75K
-91.65%6.75K
Less:Non operating expense
70.95%213.83K
54.38%80.83K
109.69%59.65K
-59.45%287.02K
-75.08%125.08K
-81.27%52.36K
-79.24%28.45K
446.89%707.82K
579.52%502.02K
414.69%279.58K
Total profit
392.26%31.83M
114.56%22.68M
495.29%11.06M
-90.38%3.54M
-86.81%6.47M
-71.04%10.57M
-89.22%1.86M
-49.59%36.76M
16.25%49M
56.65%36.5M
Less:Income tax cost
66.69%-2.92M
61.45%-2.08M
49.49%-914.09K
-1,481.85%-13.55M
-386.35%-8.78M
-249.77%-5.41M
-192.27%-1.81M
-114.91%-856.47K
-22.92%3.07M
29.93%3.61M
Net profit
127.96%34.75M
54.99%24.76M
226.47%11.97M
-54.59%17.08M
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
Net profit from continuing operation
127.96%34.75M
54.99%24.76M
226.47%11.97M
-54.59%17.08M
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
Net profit of parent company owners
127.96%34.75M
54.99%24.76M
226.47%11.97M
-54.59%17.08M
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
Earning per share
Basic earning per share
126.48%0.2489
63.64%0.18
200.00%0.09
-55.56%0.12
-74.25%0.1099
-54.17%0.11
-78.57%0.03
-65.82%0.27
-9.46%0.4268
-7.69%0.24
Diluted earning per share
126.48%0.2489
63.64%0.18
200.00%0.09
-55.56%0.12
-74.25%0.1099
-54.17%0.11
-78.57%0.03
-65.82%0.27
-9.46%0.4268
-7.69%0.24
Other composite income
-1,546.35%-79.44K
-116.44%-112.33K
-81.16K
-21.27%64.92K
-106.90%-4.82K
-162.94%-51.9K
371.96%82.46K
250.87%69.91K
161.81%82.46K
Other composite income of parent company owners
-1,546.35%-79.44K
-116.44%-112.33K
---81.16K
-21.27%64.92K
-106.90%-4.82K
-162.94%-51.9K
----
371.96%82.46K
250.87%69.91K
161.81%82.46K
Total composite income
127.51%34.67M
54.79%24.65M
224.26%11.89M
-54.52%17.15M
-66.88%15.24M
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
Total composite income of parent company owners
127.51%34.67M
54.79%24.65M
224.26%11.89M
-54.52%17.15M
-66.88%15.24M
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 31.43%514.4M32.73%352.74M29.61%169.43M11.18%544.47M6.59%391.4M11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M
Operating revenue 31.43%514.4M32.73%352.74M29.61%169.43M11.18%544.47M6.59%391.4M11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M
Other operating revenue ----134.18%14.91M----57.21%14.52M-----25.44%6.37M----36.64%9.24M----427.56%8.54M
Total operating cost 22.06%484.12M24.50%329.75M16.73%157.97M23.03%553.73M24.18%396.61M32.21%264.86M29.49%135.33M9.94%450.09M9.86%319.39M9.98%200.33M
Operating cost 24.03%370.12M25.50%254.22M16.91%121.33M22.46%414.54M24.28%298.42M35.64%202.57M33.19%103.78M11.98%338.51M13.20%240.12M16.60%149.34M
Operating tax surcharges 35.49%1.7M60.37%1.28M41.46%738.07K42.08%1.76M37.04%1.25M43.74%797.96K66.97%521.75K-25.27%1.24M-26.84%915.16K-28.30%555.13K
Operating expense 1.21%9.76M4.14%7.13M13.82%3.62M7.77%13.9M8.51%9.64M23.93%6.84M24.22%3.18M58.85%12.9M76.95%8.89M104.56%5.52M
Administration expense 43.12%70.24M47.26%46.7M43.65%23.15M24.05%75.28M11.82%49.08M10.05%31.72M21.04%16.11M-15.77%60.69M-22.93%43.89M-29.25%28.82M
Financial expense 51.32%3.51M1,172.93%1.42M-11.76%401.03K268.20%983.29K173.79%2.32M103.51%111.85K92.84%454.45K92.08%-584.6K55.44%-3.14M22.33%-3.19M
-Interest expense (Financial expense) -10.47%6.31M-10.12%4.27M-9.87%2.17M69.93%9.28M139.64%7.05M134.01%4.75M130.56%2.41M13.97%5.46M-19.27%2.94M-17.18%2.03M
-Interest Income (Financial expense) 49.72%-1.33M43.12%-1.04M36.52%-459.73K43.35%-3.13M36.69%-2.64M48.18%-1.82M76.32%-724.22K-91.64%-5.53M-857.76%-4.16M-1,698.18%-3.52M
Research and development -19.80%28.79M-16.75%19M-22.60%8.73M26.58%47.26M25.01%35.9M18.33%22.82M10.93%11.27M14.34%37.34M27.95%28.72M38.04%19.28M
Credit Impairment Loss -111.99%-2.79M-139.57%-3.36M-124.01%-1.78M-373.60%-1.29M-768.96%-1.32M-239.30%-1.4M-1,289.62%-795.77K-208.10%-273.14K-146.85%-151.34K496.16%1.01M
Asset Impairment Loss -233.57%-3.05M-166.95%-1.8M-130.93%-1.01M105.37%649.77K194.84%2.28M233.95%2.69M338.62%3.26M-458.93%-12.09M-50.42%-2.41M3.98%-2.01M
Other net revenue -85.08%1.74M-102.57%-246.69K-105.41%-344.43K691.28%12.89M597.10%11.64M1,826.45%9.59M1,226.30%6.36M-164.76%-2.18M167.16%1.67M-25.57%-555.47K
Fair value change income 29.86%5.19M1,700.31%3.31M48.23%1.77M-10.91%4.97M69.68%4M106.16%184.02K32.56%1.19M5,716.89%5.58M1,568.97%2.36M-1,110.18%-2.99M
Invest income -96.99%105.38K-98.02%105.38K-96.95%59.18K446.65%3.44M382.56%3.5M76.69%5.33M320.44%1.94M4.17%628.46K21.08%726.01K539.55%3.02M
Asset deal income ------------------------------5.8K--5.8K--3.02K
Other revenue -28.28%2.27M-46.39%1.49M-19.87%615.66K29.07%5.13M178.36%3.17M569.38%2.79M85.95%768.29K-16.79%3.97M-22.12%1.14M-66.88%416.43K
Operating profit 397.68%32.02M116.66%22.74M530.10%11.12M-90.30%3.63M-87.00%6.43M-71.45%10.5M-89.84%1.76M-48.60%37.44M17.79%49.49M58.00%36.77M
Add:Non operating Income -86.18%21.69K-89.20%13.35K-100.00%1.44619.65%189.12K2,225.16%156.95K1,731.40%123.62K1,877.39%121.61K-87.22%26.28K-96.72%6.75K-91.65%6.75K
Less:Non operating expense 70.95%213.83K54.38%80.83K109.69%59.65K-59.45%287.02K-75.08%125.08K-81.27%52.36K-79.24%28.45K446.89%707.82K579.52%502.02K414.69%279.58K
Total profit 392.26%31.83M114.56%22.68M495.29%11.06M-90.38%3.54M-86.81%6.47M-71.04%10.57M-89.22%1.86M-49.59%36.76M16.25%49M56.65%36.5M
Less:Income tax cost 66.69%-2.92M61.45%-2.08M49.49%-914.09K-1,481.85%-13.55M-386.35%-8.78M-249.77%-5.41M-192.27%-1.81M-114.91%-856.47K-22.92%3.07M29.93%3.61M
Net profit 127.96%34.75M54.99%24.76M226.47%11.97M-54.59%17.08M-66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M
Net profit from continuing operation 127.96%34.75M54.99%24.76M226.47%11.97M-54.59%17.08M-66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M
Net profit of parent company owners 127.96%34.75M54.99%24.76M226.47%11.97M-54.59%17.08M-66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M
Earning per share
Basic earning per share 126.48%0.248963.64%0.18200.00%0.09-55.56%0.12-74.25%0.1099-54.17%0.11-78.57%0.03-65.82%0.27-9.46%0.4268-7.69%0.24
Diluted earning per share 126.48%0.248963.64%0.18200.00%0.09-55.56%0.12-74.25%0.1099-54.17%0.11-78.57%0.03-65.82%0.27-9.46%0.4268-7.69%0.24
Other composite income -1,546.35%-79.44K-116.44%-112.33K-81.16K-21.27%64.92K-106.90%-4.82K-162.94%-51.9K371.96%82.46K250.87%69.91K161.81%82.46K
Other composite income of parent company owners -1,546.35%-79.44K-116.44%-112.33K---81.16K-21.27%64.92K-106.90%-4.82K-162.94%-51.9K----371.96%82.46K250.87%69.91K161.81%82.46K
Total composite income 127.51%34.67M54.79%24.65M224.26%11.89M-54.52%17.15M-66.88%15.24M-51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M
Total composite income of parent company owners 127.51%34.67M54.79%24.65M224.26%11.89M-54.52%17.15M-66.88%15.24M-51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More